Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study

By Park K.   Kim M.S.   Kim S.I.   Kim Y.S.   Moon J.I.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3556-3557

Elsevier

Access to resources Recommend Favorite

Renal recipients of haploidentical living donors treated with neoral or conventional cyclosporine: a comparative follow-up of 3 years

By Gracida C.   Melchor J.L.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1742-1743

Elsevier

Access to resources Recommend Favorite

Cyclosporine blood concentration at 2 hours (C 2 ) from drug ingestion as the best single indicator of adequate cyclosporine immunosuppression in renal allograft recipients- a four-year follow-up

By Baczkowska T.   Serafinowicz A.   Kukula K.   Nowacka-Cieciura E.   Cieciura T.   Deborska D.   Galazka Z.   Rowinski W.   Szmidt J.   Durlik M.   Lao M.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 556-557

Elsevier

Access to resources Recommend Favorite

36-Month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil

By Mucha K.   Foroncewicz B.   Paczek L.   Pazik J.   Lewandowska D.   Krawczyk A.   Pliszczynski J.   Gradowska L.   Durlik M.   Walaszewski J.   Nazarewski S.   Szmidt J.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2176-2178

Elsevier

Access to resources Recommend Favorite

Donor follow-up in living-related renal transplantation

By Zafar M.N.   Jawad F.   Aziz T.   Raza Y.   Naqvi A.   Rizvi A.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2443-2444

Elsevier

Access to resources Recommend Favorite